Press release
SGLT2 Inhibitors Market to Witness Huge Growth by 2032
The global SGLT2 Inhibitors market size is forecast to register a robust growth rate (CAGR) of 8.9% between 2024 and 2032
The global SGLT2 Inhibitors market size is forecast to register a robust growth rate (CAGR) of 8.9% between 2024 and 2032.
Key Players in This Report Include:
Astellas Pharma Inc, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals Inc
Free Sample Report + All Related Graphs & Charts @: https://www.usdanalytics.com/sample-request/25030
SGLT2 Inhibitors Market Overview in 2024
The SGLT2 Inhibitors market is being driven by the increasing incidence of type 2 diabetes worldwide. SGLT2 inhibitors, a class of medications that lower blood sugar levels by promoting glucose excretion through the urine, are gaining popularity as an effective treatment option for managing type 2 diabetes. The rising prevalence of diabetes, driven by factors such as sedentary lifestyles, poor dietary habits, and obesity, is fueling the demand for SGLT2 inhibitors. The growing awareness of the benefits of these medications in improving glycemic control and reducing cardiovascular risks is further supporting market growth.
In addition, expanding therapeutic applications are also shaping the SGLT2 Inhibitors market. Beyond their primary use in managing type 2 diabetes, SGLT2 inhibitors are being studied and approved for additional indications, such as heart failure and chronic kidney disease. Clinical trials have demonstrated the cardiovascular and renal benefits of SGLT2 inhibitors, leading to their inclusion in treatment guidelines for these conditions. The expanding therapeutic applications and the increasing recognition of the broader health benefits of SGLT2 inhibitors are driving their adoption and market expansion.
Market Segmentation and Scope:
By Drug (Sodium Glucose C-transport -2 (SGLT-2) Inhibitor, Invokana (Canagliflozin), Jardiance (Empagliflozin), Farxiga/Forxiga (Dapagliflozin), Suglat (Ipragliflozin))
USD Analytics offers enticing discounts tailored to your needs. We also provide customization options for reports to meet your specific requirements. Contact our sales team to receive a personalized report that perfectly suits your needs. Reach out today and unlock valuable insights for your business.
Enquire for customization or check for any discount if available 👉 https://www.usdanalytics.com/discount-request/25030
The report covers the competitive analysis of the market. The report identifies the most promising growth opportunities across the 6 regions and 24 countries. This section exclusively shares insight into the growth strategies of the largest market share holders helping key players and new entrants understand the investment potential in the Global SGLT2 Inhibitors Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.
Regional Analysis:
• The Middle East and Africa (South Africa, Saudi Arabia, UAE, Israel, Egypt, etc.)
• North America (United States, Mexico & Canada)
• South America (Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, etc.)
• Europe (Turkey, Spain, Turkey, Netherlands Denmark, Belgium, Switzerland, Germany, Russia UK, Italy, France, etc.)
• Asia-Pacific (Taiwan, Hong Kong, Singapore, Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia).
Furthermore, the years considered for the study are as follows:
Historical year - 2018-2023
Base year - 2023
Forecast period - 2024 to 2032
Buy Complete Assessment of SGLT2 Inhibitors Market Now @ https://www.usdanalytics.com/payment/report-25030
Major Highlights of TOC:
Chapter 1: Overview of the Global SGLT2 Inhibitors Market in 2024
1.1 SGLT2 Inhibitors Industry Analysis
1.2 Key Companies and Product Profiles
1.3 SGLT2 Inhibitors Market Segments
1.4 Industry Value Chain Analysis
1.5 Market Dynamics- Trends, Drivers, and Opportunities
1.6 Pricing Analysis
1.7 Porter's Five Forces Analysis
1.8 SWOT Profile
1.9 Macro-Economic and Demographic Impact Analysis
1.10 Scenario Analysis
Chapter 2: Global SGLT2 Inhibitors Demand Forecasts
2.1 Overview of the Segment
2.2 Global Historic SGLT2 Inhibitors Market Size (2018-2023) by Types, Applications, and Other Segments
2.3 Global Forecast SGLT2 Inhibitors Market Size (2024-2032) by Types, Applications, and Other Segments
Chapter 3: Segment-wise SGLT2 Inhibitors Market Forecasts
3.1 Key Market Segments
3.2 Premium Insights- Largest Types, Applications and Segments
3.3 Premium Insights- Most Lucrative Types, Applications, and Segments
Chapter 4: SGLT2 Inhibitors Market Outlook by Country
4.1 SGLT2 Inhibitors Market by Regions
4.2 SGLT2 Inhibitors Market Revenue Share by Region
4.3 North America (US, Canada, Mexico)
4.4 Europe (Germany, UK, France, Spain, Italy, Russia, Others)
4.5 Asia Pacific (China, Japan, India, South Korea, Australia, South East Asia, Others)
4.6 Latin America (Brazil, Argentina, Chile, Others)
4.7 Middle East and Africa (Saudi Arabia, UAE, Qatar, South Africa, Nigeria, Egypt, Others)
Player Analysis in Chapter Five
5.1 Players' Market Share Analysis (2023)
5.2 Regional Market Concentration Rates
5.3 Business Profiles, SWOT Analysis, Financial Details, Product Portfolio of Companies
..........continued
Browse Complete Summary and Table of Contents @: https://www.usdanalytics.com/industry-reports/sglt2-inhibitors-market
Thanks for reading this article; You can also get individual chapter-wise sections or region-wise report versions like North America, Middle East, Africa, Europe, MENA, LATAM, and Southeast Asia.
Harry (Business Consultant)
USD Analytics Market
Phone: +1 213-510-3499
sales@usdanalytics.com
USD Analytics is a leading information and analytics provider for customers across industries worldwide. Our high-quality research publications are connected market. Intelligence databases and consulting services support end-to-end support our customer research needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SGLT2 Inhibitors Market to Witness Huge Growth by 2032 here
News-ID: 3588913 • Views: …
More Releases from USD Analytics
Advanced Packaging Market Expecting Huge Demand in Upcoming Years
The Global Advanced Packaging Market Size is estimated at $55.2 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.3% to reach $113.1 Billion by 2034.
The latest study released on the Global Advanced Packaging Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Advanced Packaging market study covers significant research data and proofs to be a handy resource document for…
Industrial Furnace Market Is Booming So Rapidly | Andritz, Tenova, Carbolite Ger …
The Global Industrial Furnace Market Size is estimated at $12.1 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 5.1% to reach $18.9 Billion by 2034.
The latest study released on the Global Industrial Furnace Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Industrial Furnace market study covers significant research data and proofs to be a handy resource document for…
Digital Twin Market Is Booming So Rapidly | GE Digital, IBM, Microsoft
The Global Digital Twin Market Size is estimated at $17.7 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 39.4% to reach $351.8 Billion by 2034.
The latest study released on the Global Digital Twin Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Digital Twin market study covers significant research data and proofs to be a handy resource document for…
Remote Healthcare Market Expecting Huge Demand in Upcoming Years
The Global Remote Healthcare Market Size is estimated at $11.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 19.9% to reach $58.4 Billion by 2034.
The latest study released on the Global Remote Healthcare Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Remote Healthcare market study covers significant research data and proofs to be a handy resource document for…
More Releases for SGLT2
SGLT2 Inhibitors Treatment Market Current and Future Industry Landscape Analysis …
SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level.
SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetes…
SGLT2 Inhibitors Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "SGLT2 Inhibitors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of SGLT2 Inhibitors, historical and forecasted epidemiology as well as the SGLT2 Inhibitors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The SGLT2 Inhibitors market report provides current treatment practices, emerging drugs, SGLT2 Inhibitors market share of the individual therapies, and current and forecasted SGLT2 Inhibitors market size…
Report Explores the SGLT2 Inhibitors Market Latest Trends and Insights by 2024
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type II…
SGLT2 Inhibitors Market Foreseen to Grow Exponentially by 2024
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type II…
Rising Prevalence of Diabetes Across the Globe is Expected to Drive the Global S …
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type II…
SGLT2 Inhibitors Market : Key Players and Production Information analysis with F …
SGLT2 inhibitors are expected to have high consumption in the near future due to simple treatment method and relatively better results and preferred line of treatment for type II diabetes. Additionally, rising prevalence of diabetes across the globe is expected to drive the global SGLT2 inhibitors market. According to the American Diabetes Association, approximately 25.8 million people were diagnosed with diabetes in 2010 which increased to 29.1 million in 2012…
